Estimating The Budget Impact Of Adding Omalizumab To Standard Therapy In Patients With Uncontrolled Severe Allergic Asthma From Private Health Care System Perspective In Brazil
May 1, 2013, 00:00 AM
10.1016/j.jval.2013.03.1181
https://www.valueinhealthjournal.com/article/S1098-3015(13)01252-7/fulltext
Section Title :
Respiratory-Related Disorders
Section Order :
758
First Page :
A232
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(13)01252-7&doi=10.1016/j.jval.2013.03.1181